Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Remote therapy shows promise for kids with cerebral palsy

NCT ID NCT07237490

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared a special hand therapy (mCIMT) delivered via video calls to a standard home program in 42 children with unilateral cerebral palsy. The therapy group did one-hour sessions three times a week for six weeks, plus daily activities. The goal was to see if telerehabilitation could improve how children use their affected hand and their quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Dec 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion between the ages of 4-12 * Diagnosis of unilateral CP by a specialist * Ability to extend the suspected wrist more than 10° * Demonstration of ability to follow simple commands and participation in assigned tasks * Gross Motor Function Classification System Level 1 or 2 * Manual Skills Classification System Level 1, 2 or 3 * Muscle tone is normal/mild/moderate (Modified Ashworth Scale level 0-1-2) * No contractures in the upper extremity * Agrees to attend intensive therapy sessions and to stop all other upper extremity therapeutic interventions for the 3-month follow-up period Exclusion Criteria: * Significant contractures in the wrist, elbow, and fingers that prevent daily activities * Lack of active movement in the affected upper extremity * Cognitive impairment that causes inability to understand and perform simple commands and tasks * Inability to continue treatment protocol due to school schedule * Uncontrolled disease (endocrinologic, cardiovascular, pulmonary, hematologic, hepatic, renal), active systemic inflammatory disease, and/or history of malignancy * Current or previous treatments not compatible with the study treatment protocol * Orthopedic surgery (tendon transfer/tendon lengthening) performed on the affected upper extremity * Botulinum toxin injection into upper extremity muscles within the last 6 months * Dorsal rhizotomy * Intrathecal baclofen pump

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mcimt effect via telerehabilitation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istanbul University

    Istanbul, Fatih, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.